Prostate Screening

Prostate Screening

  •         Transrectal ultrasonography (TRUS)
  •         Computed tomography (CT)
  •         Magnetic resonance imaging (MRI)
  •         MRI: Diffusion-weighted imaging (DAG)
  •         MRI: Perfusion imaging
  •         MR Spectroscopy
  •         Positron emission tomography (PET)
Prostate Screening

Multiparametric prostate MRI (mp-MRI)

 Multiparametric prostate MR (mp-MRI), which was started to be developed in the 1990s and is now at a very advanced technological level, allows many complex images to be combined with the help of intravenous drugs (intravenous contrast agent). It shows the anatomical structure of the prostate in more detail. It provides the opportunity to examine and report cancerous areas in more detail and detect cancer with an accuracy rate of over 90%. There are 3 different usage techniques:

  1. MR-TRUS fusion biopsy technique

It is sampling from the targeted area by overlapping (fusing) the MR images obtained previously with the help of software and marking cancer foci with rectal ultrasound images. By combining MR and ultrasound images, 3-dimensional virtual prostate tissue is created and biopsy can be taken from the suspect area.

  1. ‘In-Bore’ biopsy technique

It is sampling from the detected area with anesthesia while the patient is in the MR device.

  1. Cognitive fusion biopsy technique

It is the use of suspicious areas previously detected in MR in the biopsy procedure accompanied by standard ultrasound performed from the breech area.

Book An Appointment